A carregar...
Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis
BACKGROUND: Targeting CTLA-4 is a recent strategic approach in cancer control: blocking CTLA-4 enhances an antitumor immunity by promoting T-cell activation and cytotoxic T-lymphocyte proliferation. This induction of a tolerance break against the tumor may be responsible for immune-related adverse e...
Na minha lista:
| Publicado no: | BMC Med |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4559965/ https://ncbi.nlm.nih.gov/pubmed/26337719 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-015-0455-8 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|